LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016
LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016
LATE-BREAKING ABSTRACT: Vocal cord dysfunction (VCD) in mild and severe asthma Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
LATE-BREAKING ABSTRACT: The analysis of the severe asthma prevalence rate in China Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016
LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013
Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
LATE-BREAKING ABSTRACT: Multinational, database cohort study to assess severe exacerbation rate in asthma Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016
Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016
Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014
LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016
Childhood obesity in relation to poor asthma control and exacerbations Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016
Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study) Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015
The asthma-COPD, overlap syndrome, our clinical experience Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014